piperacillin tazobactam
Selected indexed studies
- Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function. (J Pharm Pract, 2017) [PMID:29121839]
- Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. (Expert Rev Anti Infect Ther, 2007) [PMID:17547502]
- Does Vancomycin-Piperacillin-Tazobactam Cause Pseudo-AKI, True Nephrotoxicity, or Both? (Chest, 2023) [PMID:37558318]
_Worker-drafted node — pending editorial review._
Connections
piperacillin tazobactam is a side effect of
Sources
- Simplifying Piperacillin/Tazobactam Dosing: Pharmacodynamics of Utilizing Only 4.5 or 3.375 g Doses for Patients With Normal and Impaired Renal Function. (2017) pubmed
- Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. (2007) pubmed
- Does Vancomycin-Piperacillin-Tazobactam Cause Pseudo-AKI, True Nephrotoxicity, or Both? (2023) pubmed
- Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination. (1995) pubmed
- Pharmacokinetic evaluation of piperacillin-tazobactam. (2010) pubmed
- Does Piperacillin-Tazobactam Increase the Risk of Nephrotoxicity when Used with Vancomycin: A Meta-Analysis of Observational Trials. (2017) pubmed
- Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections. (2001) pubmed
- The Nephrotoxicity of Vancomycin. (2017) pubmed
- Piperacillin/tazobactam-induced paresthesiae. (2006) pubmed
- Delayed hypersensitivity reactions to piperacillin-tazobactam. (2021) pubmed